mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.009 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.01 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |